🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › California › Los Angeles

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Los Angeles, CA keessatti

Qorannoo 6 Leukemia Biphenotypicii Hamaa f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3
  • Children's Hospital Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • UCLA Department of Medicine, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Children's Hospital Los Angeles, Los Angeles
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Leukemia Biphenotypicii Hamaa magaalota biroo keessatti

Qorannoo biroo Los Angeles keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.